Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

OptiBiotix Health (OPTI) Regulatory News

Date Source Headline
21st Mar 2023 7:00 am RNS Change of Broker
15th Mar 2023 7:00 am RNS Slimbiome study results
21st Feb 2023 7:00 am RNS Directorate Change
30th Jan 2023 4:28 pm RNS Holding(s) in Company
5th Dec 2022 7:00 am RNS Issue of Equity – Subscription
10th Nov 2022 11:30 am RNS Investor update
1st Nov 2022 7:00 am RNS Launch of GoFigure products on Tmall China
24th Oct 2022 7:00 am RNS Approval of GoFigure products
17th Oct 2022 7:00 am RNS New health claims for SlimBiome in Australia
17th Oct 2022 7:00 am RNS New health claims for SlimBiome in Australia
28th Sep 2022 7:00 am RNS Half-year Report
26th Sep 2022 7:00 am RNS Launch of novel prebiotic in Europe and Africa
20th Sep 2022 7:00 am RNS Launch of GoFigure range with Apollo Hospitals
14th Sep 2022 7:00 am RNS New commercialisation partner in Asia Pacific
24th Aug 2022 4:41 pm RNS Second Price Monitoring Extn
24th Aug 2022 4:35 pm RNS Price Monitoring Extension
24th Aug 2022 2:06 pm RNS Second Price Monitoring Extn
24th Aug 2022 2:00 pm RNS Price Monitoring Extension
24th Aug 2022 11:06 am RNS Second Price Monitoring Extn
24th Aug 2022 11:00 am RNS Price Monitoring Extension
24th Aug 2022 9:05 am RNS Second Price Monitoring Extn
24th Aug 2022 9:00 am RNS Price Monitoring Extension
24th Aug 2022 7:00 am RNS Trading update
26th Jul 2022 12:31 pm RNS Result of AGM
20th Jul 2022 7:00 am RNS Commercial and scientific update
11th Jul 2022 7:00 am RNS Joint development agreement signed with Firmenich
1st Jul 2022 7:00 am RNS Director Appointment and Director Dealing
28th Jun 2022 7:00 am RNS Final Results
20th Jun 2022 7:00 am RNS ProBiotix Health - Appointment of CEO
31st Mar 2022 7:01 am RNS Admission of ProBiotix Health plc to AQSE
25th Mar 2022 2:36 pm RNS Director/PDMR Shareholding
18th Mar 2022 2:00 pm RNS Price Monitoring Extension
17th Mar 2022 7:00 am RNS Intention to list ProBiotix Health on AQSE
9th Mar 2022 7:00 am RNS Exercise of warrants
1st Mar 2022 7:00 am RNS Commercial Appointments
28th Feb 2022 7:00 am RNS Trading Update
9th Feb 2022 7:00 am RNS Commercial and strategy update
1st Feb 2022 7:00 am RNS Consumer study of LPLDL in Cholbiome products
27th Jan 2022 10:38 am RNS Exercise of Warrants
18th Jan 2022 7:00 am RNS Publication of third human study on LPLDL
FTSE 100 Latest
Value10,490.83
Change-3.38